Table 4.

Comparison of Barthel Index scores of acute cerebral infarction patients between the cattle encephalon glycoside and ignotin (CEGI) group and the placebo group at baseline and on days 7, 14, and 90 after treatment

		CEGI group	Placebo group	t-value	P-value
FAS analysis	Before treatment	64.2±18.2	63.5±19.7	0.28	0.778
	After treatment
	Days 7	72.9±16.2	69.5±19.9	1.37	0.174
	Days 14	82.2±14.6	76.6±18.2	2.45	0.016*
	Days 90	89.8±10.5	84.8±16.2	2.52	0.013*
PPS analysis	Before treatment	64.0±18.3	64.3±18.4	–0.14	0.889
	After treatment
	Days 7	72.7±15.9	70.8±17.5	0.87	0.383
	Days 14	82.1±14.7	77.8±16.1	2.1	0.037*
	Days 90	89.9±10.5	84.9±16.1	2.45	0.016*

Data are expressed as the mean ± SD. *P < 0.05 (rank-sum test and independent t-test). The full analysis set (FAS) consisted of 229 and 78 cases in the CEGI and placebo groups, respectively; the per-protocol set (PPS) consisted of 218 and 73 cases in the CEGI and placebo groups, respectively.